节点文献

雷米芬太尼呼吸抑制的半数有效血浆浓度的临床研究

Half-effective target plasma concentration of respiratory depression of remifentanil

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张熙哲吴新民

【Author】 Zhang Xizhe, Wu Xinmin. Department of Anesthesiology, First Hospital, Peking University, Beijing 100034 CHINA

【机构】 北京大学第一医院麻醉科北京大学第一医院麻醉科

【摘要】 目的测定靶控输注雷米芬太尼引起呼吸抑制的半数有效血浆浓度(Cp50)。方法20例择期手术病人行椎管内阻滞。按序贯法给予雷米芬太尼靶控输注20min,相邻血浆靶浓度之间比率为1·5。测定RR、SpO2、PETCO2及动脉血气。结果雷米芬太尼引起呼吸抑制的Cp50为1·8μg/L,95%可信区间为1·5~2·1μg/L。结论雷米芬太尼引起呼吸抑制的Cp50为1·8μg/L。

【Abstract】 Objective To determine the half-effective target plasma concentration (Cp 50 ) of remifentanil to cause respiratory depression. Methods Twenty patients undergoing elective operations were enrolled. Intrathecal block was given. TCI remifentanil was given by “up and down” method for 20min, and the ratio of two close plasma concentrations was 1.5. RR, SpO2, P ET CO2 and arterial gas analysis were measured. Results The CP 50 of remifentanil was 1.8 μg/L. The 95% confidence level was 1.5-2.1μg/L. Conclusion The half-effective target plasma concentration of remifentanil to cause respiratory depression was 1.8μg/L.

  • 【文献出处】 临床麻醉学杂志 ,The Journal of Clinical Anesthesiology , 编辑部邮箱 ,2006年11期
  • 【分类号】R614
  • 【被引频次】31
  • 【下载频次】170
节点文献中: 

本文链接的文献网络图示:

本文的引文网络